Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
Search
:::

常敏之 (Min-Ji Charng)

常敏之(Min-Ji Charng)圖 Return Appointment First Appointment

[Profile]

  • Education
    • MD, National Taiwan University, MD, National Taiwan University; PhD, Baylor College of medicine, USA,
    • PhD, Baylor College of medicine, USA, MD, National Taiwan University; PhD, Baylor College of medicine, USA,
  • Career and Experience
    Experiences：
  • Medical Expertise
    1. Coronary artery disease
    2. Coronary and peripheral Intervention
    3. Familial Hypercholesterolemia
    4. Pulmonary hypertension
    5. Cardiovascular genetics

[Publications]

  1. Li YH, Yeh HI, Jeng JS, Charng MJ. Comparison of the 2017 Taiwan Lipid Guidelines and the Western Lipid Guidelines for High Risk Patients. J Chin Med Assoc 2018;81:853-9.
  2. Huang CC, Charng MJ. Clinical evaluation of evolocumab for the treatment of homozygous familial hypercholesterolemia in Chinese patients. Ther Clin Risk Manag 2019;15:1209-16.
  3. Blom DJ, Harada-Shiba M, Rubba P, Gaudet D, Kastelein JJP, Charng MJ, Pordy R, Donahue S, Ali S, Dong Y, Khilla N, Banerjee P, Baccara-Dinet M, Rosenson RS. Efficacy and safety of alirocumab in adults with homozygous  familial hypercholesterolemia: The ODYSSEY HoFH trial. J Am Coll Cardiol 2020;76:131-142.
  4. Huang CC and Charng MJ. Genetic diagnosis of familial hypercholesterolemia in Asia. Front. Genet. 2020;11:833. doi: 10.3389/fgene.2020.00833.
  5. Huang CC, Niu DM, Charng MJ. Genetic analysis in a Taiwanese cohort of 750 index patients with clinically diagnosed familial hypercholesterolemia. J Atheroscler Thromb 2022;29:639-53.

限於篇幅,以上謹為代表著作